Actinium Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-26.6M | $-24.3M | $-21.0M | $-24.7M | $-10.8M | $-8.4M | $-3.4M | $-467.3K |
| Depreciation & Amortization | — | $77.5K | $53.5K | $37.9K | $1.6K | $581 | $633 | — |
| Depreciation | $55.9K | $77.5K | $53.5K | $37.9K | $1.6K | $581 | $633 | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.5M | $4.3M | $7.1M | $6.3M | $657.8K | $2.2M | $2.2M | $21.2K |
| Net Cash from Operating Activities | $-21.6M | $-20.8M | $-18.5M | $-14.3M | $-6.3M | $-5.2M | $-517.6K | $7.8K |
| Investing Activities | ||||||||
| Capital Expenditures | $24.7K | $60.0K | $47.8K | $151.7K | $16.6K | $2.4K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-24.7K | $-109.8K | $-47.8K | $-186.4K | $-16.6K | $-2.4K | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $18.8M | $15.8M | $37.5M | $15.7M | $6.2M | $5.1M | $6.0M | $-9.8K |
| Net Change in Cash | $-3.1M | $-5.1M | $18.9M | $1.2M | $-85.3K | $-85.1K | $5.5M | $-2.0K |
| Free Cash Flow | $-21.6M | $-20.8M | $-18.6M | $-14.5M | $-6.3M | $-5.2M | — | — |